The restructuring events database contains factsheets with data on large-scale restructuring events reported in the principal national media and company websites in each EU Member State. This database was created in 2002.
East (England); Bedfordshire and Hertfordshire; North and East Hertfordshire
Location of affected unit(s)
Ware
Sector
Manufacturing (20 - 21) Manufacture of chemicals and pharmaceuticals 21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations 21.1 - Manufacture of basic pharmaceutical products
150 jobs Number of planned job creations
Announcement Date
18 April 2016
Employment effect (start)
Foreseen end date
Description
Pharmaceutical company Glaxosmithkline has opened a new 56 million GBP laboratory at its site in Ware, Hertfordshire and will be creating 150 new jobs. When the new positions are filled the total head-count at the site will be 1,200. The site will manufacture inhalers to treat patients with pulmonary conditions. The company is also reported to be expanding at other sites in the UK, though the expansion at Ware is the most significant. The company has said that it expects that the majority of the new positions will be taken by people from the local area. It is not known when all the new positions will be filled.
Sources
18 April 2016: Hertfordshire Mercury
Citation
Eurofound (2016), Glaxosmithkline, Business expansion in United Kingdom, factsheet number 87367, European Restructuring Monitor. Dublin, https://apps.eurofound.europa.eu/restructuring-events/detail/87367.